Making a case for defining osteonecrosis of the jaw

Journal of Dental Research

Volumn 90, Issue 4, 2011, Pages 399-401

  Van Poznak, C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bisphosphonate; oral complications during cancer therapy; osteonecrosis of the jaw

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

BONE NECROSIS; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; CONFERENCE PAPER; HUMAN; JAW DISEASE; OSTEOMYELITIS; RISK FACTOR;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; JAW DISEASES; OSTEOMYELITIS; OSTEONECROSIS; OSTEORADIONECROSIS; RISK FACTORS;

EID: 79954612157     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510396884     Document Type: Conference Paper

References (9)

1. Barasch A., Cunha-Cruz J., Curro F., Hujoel P., Sung A., Vena D., et al. (2011). Risk factors for osteonecrosis of the jaws: a dental Practice-based Research Network case-control study. J Dent Res 90: 439-444.
2. Brown JE, Barrios CH, Diel IJ, Facon T., Fizazi K., Ibrahim T., et al. (2010). Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma. Presented at the Cancer and Bone Society 10th International Conference, Sheffield, UK, Sept. 22-25, 2010.
3. Cheung A., Seeman E. (2010). Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. New Engl J Med 363: 2473-2474.
4. Doll R., Hill AB (1950). Smoking and carcinoma of the lung. Br Med J 2: 739-748.
5. Fellows J., Rindal D., Barasch A., Gullion C., Rush W., Pihlstrom D., et al. (2011). ONJ in two dental Practice-based Research Network regions. J Dent Res 90: 433-438.
6. Khosla S., Burr D., Cauley J., Dempster DW, Ebeling PR, Felsenberg D., et al. (2007). Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22: 1479-1491. (Pubitemid 351229318)
7. Ruggiero SL, Dodson TB, Assael LA, Landesberg R., Marx RE, Mehrotra B. (2009). American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 67 (5Suppl): 2S - 12S.
8. Van Poznak C. (2006). The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer. Cancer Invest 24: 110-112. (Pubitemid 43247281)
9. Zahrowski JJ (2010). Osteonecrosis of the jaws is associated with high-dose bisphosphonate treatment in patients with cancer. J Am Dent Assoc 141: 887-888.